Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

HYTRONICS Hydrogel-based Bioelectronics for Precision Delivery

Coordinator
University of Bath, United Kingdom
Runs
1 June 2026 to 31 May 2028
Status
Running
EU funding
€260k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101281136

What the project is doing

In the project's own words, from its summary on CORDIS.

By 2050, the burden of diseases such as cancer, diabetes and neurodegenerative disorders will rise sharply. Systemic administration dominates care yet offers poor spatiotemporal control and adherence, causing dose-limiting toxicity and severe side effects (e.g., >50% chemotherapy toxicity; 50% non-adherence; 200,000 adverse drug reaction deaths annually in Europe). This demands safe, controllable, patient-tailored delivery.

HYTRONICS will revolutionise drug delivery with intelligent bioelectronic hydrogels enabling localised, on-demand, signal-triggered release, addressing limits of systemic/oral dosing (low bioavailability, enzymatic degradation) and hypodermic injection (pain, invasiveness, waste). Built from self-assembling Pluronic block copolymers, they will integrate conductivity into tissue-like structures, translating electrical cues into controllable drug release and leveraging thermoresponsive morphologies for spatiotemporal precision.

Two first-in-class systems will be built: INJECTRON, an injectable hydrogel forming an in situ depot at 37 °C for localised therapy, and FLEXTRON, a UV-crosslinked hydrogel engineered into microneedle patches for painless, user-friendly delivery. Both will be coupled with glucose fuel cells, harvesting energy from body fluids for self-powered, battery-free delivery. The fellowship will design, synthesise and validate these materials, advancing the state of the art.

By integrating expertise in materials science, bioelectronics and biomedical engineering, HYTRONICS will deliver proof-of-concept prototypes for safe, electrically controlled, closed-loop therapies. For the researcher, the fellowship will serve as a springboard to independence, providing training in bioelectronics, translational science and innovation management, while consolidating a profile ready to lead interdisciplinary projects.

For Europe, HYTRONICS will reinforce leadership in biomaterials and MedTech, benefiting patients, healthcare systems and industry.

Topics

Who is involved

OrganisationCityCountryRole
University of BathBathUnited KingdomCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI